Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2006 Feb 10

PMID 16468084

Citations 49

Authors

K J Propert

M S Litwin

Y Wang

R B Alexander

E Calhoun

J C Nickel

M P OLeary

M Pontari

M McNaughton-Collins

Affiliations

Soon will be listed here.

Abstract

Objectives: The NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) was developed to assess symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We assessed the responsiveness of the NIH-CPSI to change over time and defined thresholds for changes perceptible to patients.

Methods: We studied 174 men with CP/CPPS who participated in a placebo-controlled randomized clinical trial. Changes from baseline to six weeks in the NIH-CPSI total score and pain, urinary, and quality of life subscores were compared to a global response assessment (GRA). Effect sizes and Guyatt statistics were calculated to evaluate responsiveness; 95% confidence intervals were produced using bootstrapping.

Results: All scores decreased over time with the largest decrease in subjects who reported on the GRA that they were markedly improved. The NIH-CPSI total, pain, and quality of life scores were highly responsive in the improved groups; the urinary score showed minimal responsiveness. There was no evidence of responsiveness among those subjects who worsened on the trial. ROC curves identified a 6-point decline in the NIH-CPSI total score as the optimal threshold to predict treatment response.

Conclusions: The NIH-CPSI total score and pain and quality of life subscores are responsive to change over time.

Citing Articles

Long-term effects of pelvic floor training in male chronic pelvic pain, correlation between subjective and objective outcomes: a study protocol for a randomised controlled trial.

Hallencreutz Grape H, Nordgren B, Renstrom Koskela L BMJ Open. 2024; 14(11):e087620.

PMID: 39496364 PMC: 11535694. DOI: 10.1136/bmjopen-2024-087620.

Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment.

Castiglione R, Bertino G, Vicari B, Rizzotto A, Sidoti G, DAgati P Diseases. 2024; 12(10).

PMID: 39452503 PMC: 11508116. DOI: 10.3390/diseases12100260.

Transcatheter Arterial Embolization for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Retrospective Study of 44 Patients.

Kubo T, Shibuya M, Miyazaki K, Tsuji Y, Nakata M, Kawabe A Cardiovasc Intervent Radiol. 2024; 47(10):1348-1355.

PMID: 39191997 DOI: 10.1007/s00270-024-03842-6.

Predicting surgical efficacy and diagnosing histological inflammation: the clinical significance of prostate exosome proteins in benign prostatic hyperplasia.

Teng Z, Jin C, Wang S, Han Z, Zhang Y, Wang Y Transl Androl Urol. 2024; 13(6):930-939.

PMID: 38983479 PMC: 11228684. DOI: 10.21037/tau-23-655.

Wang X, Zhu L, Yang M, Chen Y, Liu Z World J Urol. 2024; 42(1):112.

PMID: 38431530 DOI: 10.1007/s00345-024-04791-y.

References

Deyo R, Diehr P, Patrick D . Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials. 1991; 12(4 Suppl):142S-158S. DOI: 10.1016/s0197-2456(05)80019-4. View

Alexander R, Propert K, Schaeffer A, Landis J, Nickel J, OLeary M . Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med. 2004; 141(8):581-9. DOI: 10.7326/0003-4819-141-8-200410190-00005. View

Turner J, Ciol M, Von Korff M, Berger R . Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. J Urol. 2003; 169(2):580-3. DOI: 10.1097/01.ju.0000047620.95034.a5. View

Collins M, OLeary M, Calhoun E, Pontari M, Adler A, Eremenco S . The Spanish National Institutes of Health-Chronic Prostatitis Symptom Index: translation and linguistic validation. J Urol. 2001; 166(5):1800-3. View

Litwin M, McNaughton-Collins M, Fowler Jr F, Nickel J, Calhoun E, Pontari M . The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999; 162(2):369-75. DOI: 10.1016/s0022-5347(05)68562-x. View

McNaughton Collins M, Pontari M, OLeary M, Calhoun E, SANTANNA J, Landis J . Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med. 2001; 16(10):656-62. PMC: 1495276. DOI: 10.1111/j.1525-1497.2001.01223.x. View

Shoskes D, Zeitlin S, Shahed A, Rajfer J . Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology. 1999; 54(6):960-3. DOI: 10.1016/s0090-4295(99)00358-1. View

Guyatt G, Walter S, Norman G . Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987; 40(2):171-8. DOI: 10.1016/0021-9681(87)90069-5. View

Roberts R, Jacobson D, Girman C, Rhodes T, Lieber M, Jacobsen S . Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol. 2002; 168(6):2467-71. DOI: 10.1016/S0022-5347(05)64170-5. View

10.

Nickel J, Downey J, Hunter D, Clark J . Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001; 165(3):842-5. View

11.

Barry M, Williford W, Chang Y, Machi M, Jones K, Walker-Corkery E . Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?. J Urol. 1995; 154(5):1770-4. DOI: 10.1016/s0022-5347(01)66780-6. View

12.

Propert K, Alexander R, Nickel J, Kusek J, Litwin M, Landis J . Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology. 2002; 59(6):870-6. DOI: 10.1016/s0090-4295(02)01601-1. View

13.

Guyatt G, BERMAN L, Townsend M, Taylor D . Should study subjects see their previous responses?. J Chronic Dis. 1985; 38(12):1003-7. DOI: 10.1016/0021-9681(85)90098-0. View